Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
1.350
-0.050 (-3.57%)
Nov 6, 2026, 12:27 PM EST - Market open

UPC Revenue

Universe Pharmaceuticals INC had revenue of $9.04M in the half year ending March 31, 2026, a decrease of -29.87%. This brings the company's total for the last twelve months to $17.74M, down -8.04% year-over-year. In the fiscal year ending September 30, 2025, Universe Pharmaceuticals INC had annual revenue of $17.86M, down -22.44%. That makes Universe Pharmaceuticals INC the 34,505th largest company in the world by revenue and 4,536th in the United States.

Revenue (ttm)
$17.74M
Revenue Growth
-8.04%
P/S Ratio
0.40
Revenue / Employee
$82,139
Employees
216
Market Cap
6.78M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202517.86M-5.17M-22.44%
Sep 30, 202423.02M-9.28M-28.74%
Sep 30, 202332.31M-7.83M-19.52%
Sep 30, 202240.14M-7.84M-16.34%
Sep 30, 202147.98M17.28M56.27%
Sep 30, 202030.70M-2.53M-7.60%
Sep 30, 201933.23M4.72M16.54%
Sep 30, 201828.51M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Aytu BioPharma57.57M
Biofrontera46.18M
Sonoma Pharmaceuticals21.92M
cbdMD20.93M
InMed Pharmaceuticals4.94M
TherapeuticsMD3.27M
Akanda662.47K
Gelteq314.70K
Revenue Rankings